- Coordinates
- PDB Format
- Method
- X-RAY DIFFRACTION 2.89 Å
- Oligo State
- hetero-3-2-mer
- Ligands
- 2 x C14: TETRADECANE(Non-covalent)
- 5 x LMT: DODECYL-BETA-D-MALTOSIDE(Non-covalent)
LMT.2: 11 residues within 4Å:- Chain A: G.440, G.444, M.447, C.887, A.890, L.891
- Chain C: R.8, F.11, I.15, I.18, I.19
10 PLIP interactions:3 interactions with chain A, 7 interactions with chain C- Hydrophobic interactions: A:M.447, A:A.890, C:F.11, C:I.15, C:I.18, C:I.18, C:I.19
- Hydrogen bonds: A:G.440, C:R.8, C:R.8
LMT.13: 8 residues within 4Å:- Chain B: S.530, G.533, I.534, R.536, S.537, R.540, Y.541, F.1020
5 PLIP interactions:5 interactions with chain B- Hydrophobic interactions: B:F.1020
- Hydrogen bonds: B:R.536, B:S.537, B:R.540, B:Y.541
LMT.17: 10 residues within 4Å:- Chain B: I.27, N.298, L.300, D.301, K.334, I.337, V.341, L.377, F.380, I.390
10 PLIP interactions:10 interactions with chain B- Hydrophobic interactions: B:I.27, B:I.27, B:I.337, B:L.377, B:F.380, B:F.380, B:I.390
- Hydrogen bonds: B:N.298, B:N.298, B:D.301
LMT.22: 11 residues within 4Å:- Chain C: S.530, G.533, I.534, R.536, S.537, R.540, Y.541, L.544, I.547, I.548, L.1017
9 PLIP interactions:9 interactions with chain C- Hydrophobic interactions: C:L.544, C:L.544, C:I.547, C:I.548, C:L.1017
- Hydrogen bonds: C:R.536, C:R.536, C:R.540, C:Y.541
LMT.29: 7 residues within 4Å:- Chain A: F.458
- Chain C: I.19, A.26, K.29, A.384, A.385, L.480
4 PLIP interactions:4 interactions with chain C- Hydrophobic interactions: C:I.19, C:A.385, C:L.480
- Hydrogen bonds: C:K.29
- 1 x ERY: ERYTHROMYCIN A(Non-covalent)
ERY.3: 18 residues within 4Å:- Chain A: S.79, N.81, S.134, S.135, F.136, K.292, M.573, F.615, P.616, L.668, V.672, E.673, D.681, E.683, N.719, E.826, G.861, M.862
14 PLIP interactions:14 interactions with chain A- Hydrophobic interactions: A:F.136, A:F.615, A:P.616, A:P.616, A:L.668, A:V.672, A:E.673
- Hydrogen bonds: A:S.134, A:K.292, A:K.292, A:E.673, A:N.719
- Salt bridges: A:E.683, A:E.826
- 12 x EDO: 1,2-ETHANEDIOL(Non-functional Binders)
EDO.4: 8 residues within 4Å:- Chain A: Q.218, N.231, A.232, S.233
- Chain B: S.84, N.623, T.724, P.814
1 PLIP interactions:1 interactions with chain B- Hydrogen bonds: B:T.724
EDO.5: 4 residues within 4Å:- Chain A: S.530, G.533, I.534, Y.541
No protein-ligand interaction detected (PLIP)EDO.8: 5 residues within 4Å:- Chain A: I.278, Q.584, E.585, Q.588
- Chain C: K.226
1 PLIP interactions:1 interactions with chain A- Hydrogen bonds: A:Q.584
EDO.9: 7 residues within 4Å:- Chain A: A.165, R.168, E.309
- Chain B: L.75, M.76, Y.77, N.820
3 PLIP interactions:2 interactions with chain B, 1 interactions with chain A- Hydrogen bonds: B:M.76, B:N.820, A:R.168
EDO.12: 5 residues within 4Å:- Chain A: N.744
- Chain C: T.205, K.208, A.209
- Ligands: GOL.11
1 PLIP interactions:1 interactions with chain A- Hydrogen bonds: A:N.744
EDO.14: 8 residues within 4Å:- Chain B: Q.124, R.239, Y.758, N.760, D.761
- Chain C: P.119, Q.120, E.121
4 PLIP interactions:3 interactions with chain B, 1 interactions with chain C- Hydrogen bonds: B:Q.124, B:R.239, B:D.761, C:Q.120
EDO.28: 3 residues within 4Å:- Chain C: P.224, V.225, K.226
1 PLIP interactions:1 interactions with chain C- Hydrogen bonds: C:K.226
EDO.30: 6 residues within 4Å:- Chain C: S.46, A.47, S.48, Q.125, G.126, S.128
3 PLIP interactions:3 interactions with chain C- Hydrogen bonds: C:G.126, C:S.128, C:S.128
EDO.31: 6 residues within 4Å:- Chain C: V.557, L.559, P.560, S.561, E.839, E.842
1 PLIP interactions:1 interactions with chain C- Hydrogen bonds: C:S.561
EDO.32: 3 residues within 4Å:- Chain C: D.745, R.792, A.793
3 PLIP interactions:3 interactions with chain C- Hydrogen bonds: C:R.792, C:R.792, C:R.792
EDO.33: 9 residues within 4Å:- Chain C: S.134, S.135, F.136, M.573, F.615, P.616, I.626, F.628, T.676
1 PLIP interactions:1 interactions with chain C- Hydrogen bonds: C:F.136
EDO.37: 3 residues within 4Å:- Chain E: D.72, A.75, Y.76
2 PLIP interactions:2 interactions with chain E- Hydrogen bonds: E:Y.76, E:Y.76
- 5 x GOL: GLYCEROL(Non-functional Binders)
GOL.6: 10 residues within 4Å:- Chain A: P.50, R.185, E.273, N.274, Y.275, G.755, G.756, Y.772, M.774
- Chain C: T.222
4 PLIP interactions:4 interactions with chain A- Hydrogen bonds: A:R.185, A:R.185, A:N.274, A:G.755
GOL.7: 9 residues within 4Å:- Chain A: D.566, E.567, D.568, W.634, K.643, G.994, S.997, G.998, N.1001
4 PLIP interactions:4 interactions with chain A- Hydrogen bonds: A:D.566, A:E.567, A:K.643, A:G.998
GOL.11: 9 residues within 4Å:- Chain A: I.743, N.744, N.747
- Chain C: K.208, A.209, A.212, V.214, Q.237
- Ligands: EDO.12
1 PLIP interactions:1 interactions with chain A- Hydrogen bonds: A:N.744
GOL.26: 8 residues within 4Å:- Chain A: A.688, G.689
- Chain C: A.160, N.161, D.764, R.765, R.767, K.769
3 PLIP interactions:1 interactions with chain A, 2 interactions with chain C- Water bridges: A:G.689
- Hydrogen bonds: C:R.765, C:K.769
GOL.27: 8 residues within 4Å:- Chain A: L.75, M.76, N.820
- Chain C: D.164, A.165, R.168, T.169, E.309
3 PLIP interactions:3 interactions with chain C- Hydrogen bonds: C:A.165, C:R.168, C:E.309
- 2 x D12: DODECANE(Non-covalent)
D12.10: 4 residues within 4Å:- Chain A: W.895
- Chain C: I.10, W.13, I.17
3 PLIP interactions:3 interactions with chain C- Hydrophobic interactions: C:I.10, C:W.13, C:I.17
D12.18: 10 residues within 4Å:- Chain A: F.4, R.8, F.11
- Chain B: G.440, V.443, G.444, M.447, C.887, A.890, L.891
4 PLIP interactions:3 interactions with chain A, 1 interactions with chain B- Hydrophobic interactions: A:F.11, A:F.11, A:F.11, B:L.891
- 2 x OCT: N-OCTANE(Non-covalent)
OCT.15: 6 residues within 4Å:- Chain B: M.1, F.4, F.5, F.11, I.15, I.487
3 PLIP interactions:3 interactions with chain B- Hydrophobic interactions: B:F.4, B:F.4, B:F.5
OCT.23: 7 residues within 4Å:- Chain C: M.1, Q.439, V.443, V.482, L.483, L.486
- Ligands: HEX.35
2 PLIP interactions:2 interactions with chain C- Hydrophobic interactions: C:V.482, C:L.486
- 2 x HEX: HEXANE(Non-covalent)(Non-functional Binders)
HEX.16: 9 residues within 4Å:- Chain B: V.452, M.456, F.459, Y.467, L.876, Y.877, S.880, Q.928, L.932
4 PLIP interactions:4 interactions with chain B- Hydrophobic interactions: B:M.456, B:Y.877, B:Y.877, B:L.932
HEX.35: 6 residues within 4Å:- Chain C: Q.439, V.443, M.447, L.891
- Ligands: DDQ.20, OCT.23
No protein-ligand interaction detected (PLIP)- 1 x 3YI: (2S,12Z,14E,16S,17S,18R,19R,20R,21S,22R,23S,24E)-8-formyl-5,6,9,17,19-pentahydroxy-23-methoxy-2,4,12,16,18,20,22-heptam ethyl-1,11-dioxo-1,2-dihydro-2,7-(epoxypentadeca[1,11,13]trienoimino)naphtho[2,1-b]furan-21-yl acetate(Non-covalent)
3YI.19: 13 residues within 4Å:- Chain B: M.575, F.617, A.618, F.664, F.666, L.668, P.669, T.676, R.717, N.719, G.720, R.815, L.828
13 PLIP interactions:13 interactions with chain B- Hydrophobic interactions: B:F.617, B:F.664, B:F.666, B:L.668
- Hydrogen bonds: B:A.618, B:R.717, B:R.717, B:N.719, B:N.719, B:N.719
- Water bridges: B:E.826
- Salt bridges: B:R.717
- pi-Stacking: B:F.617
- 1 x DDQ: DECYLAMINE-N,N-DIMETHYL-N-OXIDE(Non-covalent)
- 2 x SO4: SULFATE ION(Non-functional Binders)
- 1 x PG4: TETRAETHYLENE GLYCOL(Non-functional Binders)
- 1 x PTY: PHOSPHATIDYLETHANOLAMINE(Non-covalent)
PTY.34: 13 residues within 4Å:- Chain B: I.10, W.13, I.17, L.21
- Chain C: I.882, F.885, L.886, E.893, S.894, W.895, S.896, R.1030, F.1033
14 PLIP interactions:11 interactions with chain C, 3 interactions with chain B- Hydrophobic interactions: C:I.882, C:F.885, C:L.886, C:W.895, C:W.895, C:W.895, C:W.895, B:I.10, B:W.13, B:W.13
- Hydrogen bonds: C:E.893, C:W.895, C:S.896
- Salt bridges: C:R.1030
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Tam, H.K. et al., Allosteric drug transport mechanism of multidrug transporter AcrB. Nat Commun (2021)
- Release Date
- 2021-05-19
- Peptides
- Multidrug efflux pump subunit AcrB: ABC
DARPIN: DE - SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AB
BC
CD
DE
E - Membrane
-
We predict this structure to be a membrane protein.
- Coordinates
- PDB Format
- Method
- X-RAY DIFFRACTION 2.89 Å
- Oligo State
- hetero-3-2-mer
- Ligands
- 2 x C14: TETRADECANE(Non-covalent)
- 5 x LMT: DODECYL-BETA-D-MALTOSIDE(Non-covalent)
- 1 x ERY: ERYTHROMYCIN A(Non-covalent)
- 12 x EDO: 1,2-ETHANEDIOL(Non-functional Binders)
- 5 x GOL: GLYCEROL(Non-functional Binders)
- 2 x D12: DODECANE(Non-covalent)
- 2 x OCT: N-OCTANE(Non-covalent)
- 2 x HEX: HEXANE(Non-covalent)(Non-functional Binders)
- 1 x 3YI: (2S,12Z,14E,16S,17S,18R,19R,20R,21S,22R,23S,24E)-8-formyl-5,6,9,17,19-pentahydroxy-23-methoxy-2,4,12,16,18,20,22-heptam ethyl-1,11-dioxo-1,2-dihydro-2,7-(epoxypentadeca[1,11,13]trienoimino)naphtho[2,1-b]furan-21-yl acetate(Non-covalent)
- 1 x DDQ: DECYLAMINE-N,N-DIMETHYL-N-OXIDE(Non-covalent)
- 2 x SO4: SULFATE ION(Non-functional Binders)
- 1 x PG4: TETRAETHYLENE GLYCOL(Non-functional Binders)
- 1 x PTY: PHOSPHATIDYLETHANOLAMINE(Non-covalent)
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Tam, H.K. et al., Allosteric drug transport mechanism of multidrug transporter AcrB. Nat Commun (2021)
- Release Date
- 2021-05-19
- Peptides
- Multidrug efflux pump subunit AcrB: ABC
DARPIN: DE - SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AB
BC
CD
DE
E - Membrane
-
We predict this structure to be a membrane protein.